Refractory Cancer: What It Is and How It Is Treated

What does “refractory” mean medically? The word “refractory” in general use means stubborn or intractable, and in medicine it is specifically applied to disease that does not respond to treatment. Refractory cancer refers to cancer that may be resistant to initial therapy or becomes resistant during treatment. “We would consider disease refractory if doesn’t respond … Read more

PALB2 Breast Cancer Gene: What You Should Know

A relatively small proportion of breast cancers are caused by alterations in inherited genes that sharply increase the lifetime risk of developing breast cancer. One of these genes has recently been receiving new attention: PALB2, a potent breast cancer susceptibility gene related to the better-known BRCA1 and BRCA2 genes. Someone who inherits a PALB2 mutation faces … Read more

New ‘Almanac’ Tool of Tumor Molecular Changes Could Aid Precision Cancer Care

Researchers at Dana-Farber and the Broad Institute of MIT and Harvard have created a novel Molecular Oncology Almanac that combines an algorithm, or computational method, for interpreting genomic alterations in a patient’s tumor, along with a knowledge base of molecular changes reported to be associated with tumor behavior. They say that the components of this … Read more

What Are Radiopharmaceuticals and How Are They Used in Cancer?

Drugs that contain radioactive isotopes — forms of chemical elements that emit radiation — are known as radiopharmaceuticals. Radioisotopes have been used to treat cancer as far back as the 1940s, but the field has really taken off just in the past few years as researchers explore their potential in cancer. How are radiopharmaceuticals used … Read more

Shocked By His Breast Cancer Diagnosis, One Man Spreads the Word

Michael Tichnor still wonders what might have happened if his primary care physician did not ask him one last question during his annual physical two years ago: “Is there anything else you want to tell me?” Until that moment, Tichnor, then 66, had no plans to mention the pebble-sized bump he accidentally discovered on his … Read more

What are Cancer Vaccines?

Cancer vaccines are a form of immunotherapy aimed at enhancing the immune system’s ability to recognize and attack cancer cells, or to protect against certain forms of cancer caused by viruses. Vaccine can help prevent some cancers There are two approved preventive vaccines directed against cancer-causing viruses.  Vaccines against cancer-causing or other infectious microbes typically … Read more

Colorectal Cancer in the Black Community: Information to Know

Communities of color, particularly Black Americans, have long faced health disparities and a disproportionate burden of cancer. Colorectal cancer is no exception. Colorectal cancer occurs at a higher rate in Black Americans than any other racial or ethnic group in the U.S., according to the American Cancer Society. African Americans are more than 20% more … Read more

Cancer Care in Transgender Youth Patients: Things to Consider

If transgender youth and adults are undergoing (or planning) gender-affirming surgery, taking masculinizing or feminizing hormones, and they have cancer, these treatments can have implications for their care. Cancer treatments in turn can have implications for their gender-affirming care. Oncologists should take gender identity into account in making decisions about cancer treatment. This starts with … Read more

Resurrecting an Alternative Treatment for NER-Deficient Bladder Cancer Patients

Discovering new cancer treatment can sometimes be a matter of connecting the dots between new pathways and old drugs. That was the case in a new paper in the TKTK issue of Clinical Cancer Research co-authored by Kent Mouw MD, PhD, co-director of Dana-Farber’s Bladder Cancer Center. Mouw and his team found a promising way … Read more

Form of Artificial Intelligence Proves Superior in Identifying Inherited Cancer-Related DNA Variants

A new “deep learning” form of artificial intelligence outperformed standard methods in identifying cancer patients with inherited DNA alterations that could increase their risk of developing cancer or improve their response to certain targeted cancer drugs. Dana-Farber researchers led by Saud H. AlDubayan, MD, and Eliezer Van Allen, MD, report in JAMA that the analytical … Read more

Cancer Prevention and Care Resources for Marginalized Patients and Advocates

Cancer does not affect everyone in the same way. A combination of factors, including race, ethnicity, sexual orientation, or socioeconomic status can make some patients face a greater cancer burden and poorer outcomes in cancer care and treatment. These inequities are called cancer disparities. The causes “are complex and reflect social and economic disparities and … Read more

What are Cancer Disparities and How Are Dana-Farber Researchers Addressing Them?

Despite enormous advances in cancer treatment, some racial, ethnic, and socioeconomic groups still bear an especially large burden from the disease, with higher incidence rates for many cancers and poorer outcomes. Decades of research has documented these disparities. Among adult patients, for example, African Americans have the highest mortality rate of any racial or ethnic … Read more

Ovarian Cancer Clinical Trial Helps Grandmother Feel Stable During a Difficult Year

Carol Brown, 80, has been through quite a turbulent 2020. Her much-beloved pastimes, including playing violin in a senior orchestra, book groups, and weekly church services, are now virtual due to the COVID-19 pandemic. The Boston-area resident had to cancel a March trip to visit family out west, and she spent the summer packing up … Read more

Should I Get Screened for Cancer During COVID-19?

Many people skipped or delayed routine cancer screening tests during the early months of the coronavirus pandemic. Medical providers say it’s now safe and prudent to schedule your appointments.  “If you put off your cancer screening mammograms or other screening procedures, we encourage you to reschedule them now,” says Craig Bunnell, MD, MPH, Dana-Farber’s chief … Read more